The National Institutes of Health (NIH) is offering the Developmental Pharmacology and Toxicology (R21) Grant for vital research. This funding encourages multidisciplinary, investigator-initiated basic and translational applications. Its primary purpose is to explore the critical role of ontogeny—the developmental process from fetal life to adolescence—on key biological components. Specifically, it focuses on how drug metabolizing enzymes, transporters, receptors, and signaling pathways are influenced across diverse developmental periods. This initiative aims to advance understanding of drug action and toxicity as biological systems mature, enhancing pharmacological and toxicological knowledge for improved health outcomes.
Opportunity ID: 239455
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-308 |
| Funding Opportunity Title: | Developmental Pharmacology and Toxicology: Role of Ontogeny (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Environment Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.113 — Environmental Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 07, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2016 |
| Current Closing Date for Applications: | Sep 07, 2016 |
| Archive Date: | Oct 08, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments Native American tribal governments (Federally recognized) Private institutions of higher education For profit organizations other than small businesses Small businesses State governments Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages grant applications for research related to developmental pharmacology and toxicology. A major goal is to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology and toxicology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways across developmental periods from fetal life to adolescence. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-308.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | Forms-C | PKG00182653 | Sep 16, 2013 | May 07, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222400 | Apr 17, 2016 | Sep 07, 2016 | View |
Package 1
Mandatory forms
239455 RR_SF424_2_0-2.0.pdf
239455 PHS398_ResearchPlan_2_0-2.0.pdf
239455 PHS398_CoverPageSupplement_2_0-2.0.pdf
239455 RR_KeyPersonExpanded_2_0-2.0.pdf
239455 RR_OtherProjectInfo_1_3-1.3.pdf
239455 PerformanceSite_2_0-2.0.pdf
Optional forms
239455 RR_SubawardBudget30_1_3-1.3.pdf
239455 PlannedReport-1.0.pdf
239455 PHS398_CumulativeInclusionReport-1.0.pdf
239455 PHS398_ModularBudget_1_2-1.2.pdf
239455 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
239455 RR_SF424_2_0-2.0.pdf
239455 PHS398_CoverPageSupplement_3_0-3.0.pdf
239455 RR_OtherProjectInfo_1_3-1.3.pdf
239455 PerformanceSite_2_0-2.0.pdf
239455 RR_KeyPersonExpanded_2_0-2.0.pdf
239455 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
239455 RR_Budget_1_3-1.3.pdf
239455 RR_SubawardBudget30_1_3-1.3.pdf
239455 PHS398_ModularBudget_1_2-1.2.pdf
239455 PHS_Inclusion_Enrollment_Report-1.0.pdf
239455 PHS_AssignmentRequestForm-1.0.pdf